Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Future Oncology (London, England)|April 9, 2010
Past, present and future of therapies in pediatric sarcomasPooja Hingorani, Edward A KolbPediatric Blood & Cancer|September 11, 2012
BIRC5 expression is a poor prognostic marker in Ewing sarcomaPooja Hingorani, Paul Dickman, Pamela Garcia-Filion, et al.Cancer Medicine|June 14, 2019
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology GroupRajaram Nagarajan, Robert Gerbing, Todd Alonzo, et al.Pediatric Radiology|September 18, 2007
The neuroradiological findings in a case of Revesz syndromeMeir H Scheinfeld, Yvonne W Lui, Edward A Kolb, et al.Oncotarget|November 19, 2016
Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcomaValerie B Sampson, Nancy S Vetter, Wendong Zhang, et al.Frontiers in Oncology|May 9, 2024
Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemiaSonia Ahmed, Mariam Elsherif, Dina Yassin, et al.Molecular Cancer Therapeutics|December 10, 2020
ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing ConsortiumPooja Hingorani, Michael E Roth, Yifei Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2024
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology GroupVivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, et al.JAMA Oncology|November 11, 2021
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 TrialMatthew A Kutny, Todd A Alonzo, Oussama Abla, et al.Blood|September 28, 2021
The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AMLEmily B Heikamp, Jill A Henrich, Florian Perner, et al.Pageof 2